Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis.

2017 | JOURNAL DOI: 10.1016/J.EJCA.2017.08.018

1-min quiz | Figure out your research career

See how Impactio can help you with your research career.

Start